DOI:
10.1055/s-00000169
American Journal of Perinatology Reports
LinksClose Window
References
Greenbaum LA, Fila M, Ardissino G. et al.
Eculizumab is a safe and effective treatment in pediatric patients with atypical hemolytic uremic syndrome.
Kidney Int 2016;
89 (03) 701-711
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.